Diabetes Innovation Challenge

Diabetes Innovation Challenge 2017-02-17T13:01:23+00:00

2016 Diabetes Innovation Challenge—Award Recipients

T1D Exchange, an organization accelerating research to improve outcomes in type 1 diabetes, and M2D2, a joint venture of the University of Massachusetts Lowell and Worcester campuses that incubates medical device start-ups, announced the winners for the first annual Diabetes Innovation Challenge. The competition is the first-ever, open, worldwide challenge to identify and accelerate transformational advancements in diabetes research and care. T1D Exchange and M2D2 are working in partnership on the inaugural event with sponsorship support from JDRF and the American Diabetes Association (ADA), among others.

From an impressive field of over 60 inspiring applicants, the winners of the 2016 Diabetes Innovation Challenge include:
Early-to-preclinical stage
1st – Integrated Medical, Irvine, CA
Fully-integrated, low cost, implantable, wireless, continuous glucose monitoring platform.

2nd- Glyscend, Baltimore, MD
Orally-administered intestinal coating which mimics the therapeutic benefits of bariatric surgery on type 2 diabetes.

3rd – WindGap Medical, Somerville, MA
Autoinjector that automates the rehydration and administration of lyophilized drugs, such as glucagon.

Late-stage (pre-clinical through translational)
1st – Enable Biosciences, San Francisco, CA
Ultrasensitive non-radioactive autoantibody test that can be readily used for population screening.

2nd- Admetsys, Boston, MA
Artificial pancreas system specifically for the needs of diabetics in-hospital.

3rd- Polyphotonix, Durham, UK
Non-invasive, low cost diabetic retinopathy mask that can be used by the patient in their own home while asleep.

People’s Choice – Sproutel, Providence, RI. The teddy bear teaching tool.

Thank you for your support of the 2016 Diabetes Innovation Challenge.
For further coverage of the event, please visit the news section of our website, https://t1dexchange.org/pages/impact/news/